Quality of Public Sector Care for Schizophrenia in Arkansas
Tóm tắt
Objective: Using process-of-care indicators, we examined the quality of care provided to 139 individuals receiving treatment for schizophrenia in public sector systems. Methods: Longitudinal data on services use and medication management were abstracted from medical records. Medication adherence data were obtained by self- and informant reports. Results: Overall, 39% of participants had less than monthly contact with community-based service (CBS) providers. When participants in day treatment or partial hospitalization programs were excluded, less than monthly CBS contact increased to 70%. Of participants, 40%–60% were prescribed medications outside guideline-recommended dose ranges. Up to half of participants reported taking half or less of prescribed antipsychotics. The adverse impact on patient outcomes of these practice patterns is well established. Conclusions: Public sector organizations face powerful challenges to the behavioral changes needed to sustain best practice care. Overcoming these challenges to assure high-quality care for schizophrenia will require tremendous creativity and commitment.
Tài liệu tham khảo
American Psychiatric Association. (1997). American Psychiatric Association: Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154(4), 1–63.
Attkisson, C. (1992). Clinical services research. Schizophrenia Bulletin, 18(4), 561–626.
Attkisson, C. C., McIntyre, M. H., Hargreaves, W. A., Harris, M. R., & Ochberg, F. M. (1974). A working model for mental health program evaluation. American Journal of Orthopsychiatry, 44, 741–753.
Baldessarini, R. J., Cohen, B. M., & Teicher, M. H. (1988). Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry, 45, 79–91.
Baldessarini, R. J., Katz, B., & Cotton, P. (1984). Dissimilar dosing with high-potency and low-potency neuroleptics. American Journal of Psychiatry, 141, 748–752.
Cuffel, B. J., Fischer, E. P., Owen, R. R., & Smith, G. R. (1997). An instrument for measurement of outcomes of care of schizophrenia: Issues in development and implementation. Evaluation and the Health Professions, 20(1), 96–108.
Davis, D. A., Thomson, M. A., Oxman, A. D., & Haynes, R. B. (1995). Changing physician performance: A systematic review of the effect of continuing medical education strategies. Journal of the American Medical Association, 274(9), 700–705.
Dixon, L. B., Lehman, A. F., & Levine, J. (1995). Conventional antipsychotic medications for schizophrenia. Schizophrenia Bulletin, 21(4), 567–577.
Donabedian, A. (1966). Evaluating the quality of medical care. Milbank Quarterly, 44(2), 166–206.
Fischer, E. P., Lehman, A. F., Cuffel, B. J., & Heithoff, K. A. (1997). Development and testing of a brief instrument to assess outcomes of care in schizophrenia. Final Report to the Department of Veterans Affairs Health Services Research and Development Service SDR 91–005.
Fischer, E. P., Owen, R. R., & Cuffel, B. J. (1996). Substance abuse, community service use, and symptom severity of urban and rural residents with schizophrenia. Psychiatric Services, 47(9) 980–984.
Frances, A., Docherty, J., & Kahn, D. A. (1996). The Expert Consensus Guideline Series: Treatment of Schizophrenia. Journal of Clinical Psychiatry, 57, 1–59.
Grimshaw, J. M., & Russell, I. T. (1993). Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet, 342, 1317–1322.
Hewitt, M. (1989). Defining “rural” areas: Impact on health care policy and research. Washington, DC: U.S. Government Printing Office.
Johnson, R. E., & McFarland, B. H. (1993). Antipsychotic drug exposure in a health maintenance organization. Medical Care, 31, 432–444.
Kane, J. M. (1992). New developments in the pharmacological treatment of schizophrenia. Bulletin of the Menninger Clinic, 56, 62–75.
Katon, W., Von Korff, M., Lin, E., Unutzer, J., Simon, G., Walker, E., Ludman, E., & Bush, T. (1997). Population-based care of depression: Effective disease management strategies to decrease prevalence. General Hospital Psychiatry, 19, 169–178.
Katon, W., Von Korff, M., Lin, E., Walker, E., Simon, G., Bush, T., & Russo, J. (1995). Collaborative management to achieve treatment guidelines: Impact on depression in primary care. Journal of the Americian Medical Association, 273(13), 1026–1031.
Lehman, A. F. (1996). Quality of Life Interview (QOLI). In L. I. Sederer & B. Dickey (Eds.), Outcomes assessment in clinical practice (pp. 117–119). Baltimore, MD: Williams & Wilkins.
Lehman, A. F., Steinwachs, D. M., & Co-investigators of the PORT Project. (1998a). Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24(1), 1–10.
Lehman, A. F., Steinwachs, D. M., & Survey Co-investigators of the PORT Project. (1998b). Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin, 24(1), 11–20.
Lin, E., Katon, W., Simon, G., Von Korff, M., Bush, T., Rutter, C., Saunders, K., & Walker, E. (1997). Achieving guidelines for the treatment of depression in primary care: Is physician education enough? Medical Care, 35, 831–842.
Lukoff, D., Nuechterlein, K. H., & Ventura, J. (1986). Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin, 12(4), 594–602.
Mayefsky, J. H., & Foyer, H. R. (1993). Use of a chart audit: Teaching well child care to pediatric house officers. Medical Education, 27, 170–174.
Mental Health Strategic Health Care Group, Psychosis Working Group, Office of Performance and Quality, & VHA Headquarters. (1997). Veterans Health Administration clinical guideline for management of persons with psychoses. Washington, DC: Veterans Health Administration.
Miklowitz, D. J., Goldstein, M. J., Nuechterlein, K. H., Snyder, K. S., & Doane, J. A. (1986). Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacology Bulletin, 22(3), 628–632.
Miklowitz, D. J., Goldstein, M. J., Nuechterlein, K. H., Snyder, K. S., & Mintz, J. (1988). Family factors and the course of bipolar affective disorder. Archives of General Psychiatry, 45, 225–231.
Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812.
Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47(8), 853–858.
Raisch, D. W., Bootman, J. L., Larson, L. N., & McGhan, W. F. (1990). Improving antiulcer agent prescribing in a health maintenance organization. American Journal of Hospital Pharmacy, 47, 1766–1773.
Rickels, K., & Briscoe, E. (1970). Assessment of dosage deviation in outpatient drug research. Journal of Clinical Pharmacology, 10(3), 153–160.
SAS Institute Inc. (1989). SAS/STAT Users Guide, Version 6, Fourth Edition, Volume 1. Cary, NC: Author.
Spitzer, R. L., & Williams, J. B. W. (1990). User's guide for the Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.
Sullivan, G., Jackson, C. A., & Spritzer, K. L. (1996). Characteristics and service use of seriously mentally ill persons living in rural areas. Psychiatric Services, 47(1), 57–61.
Tierney, W. M., Miller, M. E., & McDonald, C. J. (1990). The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. New England Journal of Medicine, 322, 1499–1504.
Young, A. S., Sullivan, G., Burnam, M. A., & Brook, R. H. (1998). Measuring the quality of outpatient treatment for schizophrenia. Archives of General Psychiatry, 55(7), 611–617.